CD ComputaBio specializes in advanced computational biology solutions, utilizing cutting-edge technologies such as AlphaFold 3 for protein folding and AI-based protein design. Their services encompass a wide range of applications, including molecular dynamics simulations, drug design, and bioinformatics, aimed at enhancing drug discovery processes. The company employs state-of-the-art tools and software to provide accurate predictions and robust analyses, ensuring rapid turnaround times without compromising quality. Their multidisciplinary team combines expertise in bioinformatics and computational chemistry, allowing them to offer customized solutions tailored to the specific needs of researchers, biotechnologists, and pharmaceutical companies.

In addition to their core services, CD ComputaBio is at the forefront of innovative approaches like PROTAC drug development, which leverages computational modeling and machine learning to create targeted therapeutics. Their offerings include comprehensive solutions for antibody drug discovery, multitarget drug design, and various bioinformatics services, all designed to facilitate the development of life-changing therapeutics. By focusing on client needs and fostering interdisciplinary collaboration, CD ComputaBio aims to lead advancements in computational biology, ultimately contributing to the evolution of modern drug discovery.

United States

CD ComputaBio is a professional computational biology service company. Our service spans across different areas in computational biology, providing access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. We are committed to providing high-quality data and customer service to various industrial and academic customers.

CD ComputaBio

Company Details